SCHEMBL25429844

SCHEMBL25429844

O=Cc1cc(Cl)n[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25429060 0.75 — —
SCHEMBL12500579 0.72 — —
SCHEMBL20168010 0.70 — —
SCHEMBL18985097 0.70 — —
SCHEMBL30730308 0.70 — —
SCHEMBL28308403 0.70 — —
SCHEMBL27953974 0.69 — —
SCHEMBL15728413 0.69 HCAR2 (0.42) —
SCHEMBL21810960 0.65 HCAR2 (1.00) —
SCHEMBL27766234 0.65 HCAR2 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023151636-A1 HETEROCYCLIC COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH BEIGENE , LTD. (KY) 2023-08-17 — — WO disclosed
WO-2023151640-A1 HETEROCYCLIC COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH BEIGENE , LTD. (KY) 2023-08-17 — — WO disclosed
CN-106715419-A Aminotriazine derivatives as TANK-binding kinase inhibitor compounds 吉利德科学公司 2017-05-24 — — CN disclosed
Send feedback